{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease; Parkinson\u2019s disease", "Neurodegeneration", "Neurodegenerative diseases", "Therapeutic management"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33687588", "DateCompleted": {"Year": "2021", "Month": "07", "Day": "27"}, "DateRevised": {"Year": "2021", "Month": "07", "Day": "27"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "03", "Day": "09"}], "Language": ["eng"], "ELocationID": ["10.1007/s11010-021-04120-6"], "Journal": {"ISSN": "1573-4919", "JournalIssue": {"Volume": "476", "Issue": "7", "PubDate": {"Year": "2021", "Month": "Jul"}}, "Title": "Molecular and cellular biochemistry", "ISOAbbreviation": "Mol Cell Biochem"}, "ArticleTitle": "Mechanistic insights into the pathogenesis of neurodegenerative diseases: towards the development of effective therapy.", "Pagination": {"StartPage": "2739", "EndPage": "2752", "MedlinePgn": "2739-2752"}, "Abstract": {"AbstractText": ["Neurodegeneration is a prevalent and one of the emerging reasons for morbidity, mortality, and cognitive impairment in aging. Dementia is one of such conditions of neurodegeneration, partially manageable, irreversible, and worsens over time. This review is focused on biological and psychosocial risk factors associated with Alzheimer's and Parkinson's diseases, highlighting the value of cognitive decline. We further emphasized on current therapeutic strategies from pharmacological and non-pharmacological perspectives focusing on their effects on cognitive impairment, protein aggregation, tau pathology, and improving the quality of life. Deeper mechanistic insights into the multifactorial neurodegeneration could offer the design and development of promising diagnostic and therapeutic strategies."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Section of Psychology, Women's College, Aligarh Muslim University, Aligarh, UP, 202002, India."}], "LastName": "Nazam", "ForeName": "Fauzia", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biotechnology, Yeungnam University, Gyeongsan, 38541, Republic of Korea."}], "LastName": "Shaikh", "ForeName": "Sibhghatulla", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida, Uttar Pradesh, 201313, India. nazianazam@gmail.com."}], "LastName": "Nazam", "ForeName": "Nazia", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Najran University, P.O. Box- 1988, Najran, Saudi Arabia."}], "LastName": "Alshahrani", "ForeName": "Abdulaziz Saad", "Initials": "AS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, College of Medicine, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Al-Kharj, 11942, Kingdom of Saudi Arabia."}], "LastName": "Hasan", "ForeName": "Gulam Mustafa", "Initials": "GM"}, {"Identifier": ["0000-0002-3663-4940"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, 110025, India. mihassan@jmi.ac.in."}], "LastName": "Hassan", "ForeName": "Md Imtaiyaz", "Initials": "MI"}], "GrantList": [{"GrantID": "Z. 18017/187/CSS/R&D/DL-01/2019-20-NMPB-IVA", "Agency": "National Medicinal Plants Board, Ministry of AYUSH, Government of India", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Mol Cell Biochem", "NlmUniqueID": "0364456", "ISSNLinking": "0300-8177"}, "MeshHeadingList": [{"QualifierName": ["metabolism", "pathology", "therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism", "pathology", "therapy"], "DescriptorName": "Cognitive Dysfunction"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism", "pathology", "therapy"], "DescriptorName": "Parkinson Disease"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Enache D, Winblad B, Aarsland D (2011) Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry 24:461\u2013472", "ArticleIdList": ["21926624"]}, {"Citation": "Kasl-Godley J, Gatz M (2000) Psychosocial interventions for individuals with dementia: an integration of theory, therapy, and a clinical understanding of dementia. Clin Psychol Rev 20:755\u2013782", "ArticleIdList": ["10983267"]}, {"Citation": "Kumar V, Sami N, Kashav T, Islam A, Ahmad F, Hassan MI (2016) Protein aggregation and neurodegenerative diseases: from theory to therapy. Eur J Med Chem 124:1105\u20131120", "ArticleIdList": ["27486076"]}, {"Citation": "Voet S, Srinivasan S, Lamkanfi M, van Loo G (2019) Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med 11:e10248", "ArticleIdList": ["31015277", "6554670"]}, {"Citation": "Rocca WA (2018) The burden of Parkinson\u2019s disease: a worldwide perspective. Lancet Neurol 17:928\u2013929", "ArticleIdList": ["30287052"]}, {"Citation": "Srinageshwar B, Petersen RB, Dunbar GL, Rossignol J (2020) Prion-like mechanisms in neurodegenerative disease: implications for Huntington\u2019s disease therapy. Stem Cells Transl Med 9:559\u2013566", "ArticleIdList": ["31997581", "7180288"]}, {"Citation": "Kumar V, Islam A, Hassan MI, Ahmad F (2016) Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning. Eur J Med Chem 121:903\u2013917", "ArticleIdList": ["27372371"]}, {"Citation": "Kumar V, Islam A, Hassan MI, Ahmad F (2016) Delineating the relationship between amyotrophic lateral sclerosis and frontotemporal dementia: sequence and structure-based predictions. Biochimica et Biophysica Acta Mol Basis Dis 1862:1742\u20131754"}, {"Citation": "Sami N, Rahman S, Kumar V, Zaidi S, Islam A, Ali S, Ahmad F, Hassan MI (2017) Protein aggregation, misfolding and consequential human neurodegenerative diseases. Int J Neurosci 127:1047\u20131057", "ArticleIdList": ["28110595"]}, {"Citation": "As A (2018) 2018 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 14:367\u2013429"}, {"Citation": "Wood-Kaczmar A, Gandhi S, Wood N (2006) Understanding the molecular causes of Parkinson\u2019s disease. Trends Mol Med 12:521\u2013528", "ArticleIdList": ["17027339"]}, {"Citation": "Klein C, Westenberger A (2012) Genetics of Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2:a008888", "ArticleIdList": ["22315721", "3253033"]}, {"Citation": "Karch CM, Cruchaga C, Goate AM (2014) Alzheimer\u2019s disease genetics: from the bench to the clinic. Neuron 83:11\u201326", "ArticleIdList": ["24991952", "4120741"]}, {"Citation": "Kalia LV, Lang AE, Hazrati L-N, Fujioka S, Wszolek ZK, Dickson DW, Ross OA, Van Deerlin VM, Trojanowski JQ, Hurtig HI (2015) Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol 72:100\u2013105", "ArticleIdList": ["25401511", "4399368"]}, {"Citation": "Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor J-P, Thomas A (2019) Dementia with Lewy bodies: an update and outlook. Mol Neurodegener 14:1\u201318"}, {"Citation": "Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M (2014) Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease. Nat Genet 46:989\u2013993", "ArticleIdList": ["25064009", "4146673"]}, {"Citation": "Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA, Noyce AJ, Xue A (2019) Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol 18:1091\u20131102", "ArticleIdList": ["31701892"]}, {"Citation": "Kang SS, Zhang Z, Liu X, Manfredsson FP, Benskey MJ, Cao X, Xu J, Sun YE, Ye K (2017) TrkB neurotrophic activities are blocked by \u03b1-synuclein, triggering dopaminergic cell death in Parkinson\u2019s disease. Proc Natl Acad Sci 114:10773\u201310778", "ArticleIdList": ["28923922"]}, {"Citation": "Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M, Maraganore D, Gwinn-Hardy K, Wszolek Z, Dickson D (2004) Comparison of kindreds with parkinsonism and \u03b1-synuclein genomic multiplications. Annal Neurol 55:174\u2013179", "ArticleIdList": ["14755720"]}, {"Citation": "Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R (1997) Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047", "ArticleIdList": ["9197268"]}, {"Citation": "Pupyshev AB, Korolenko TA, Akopyan AA, Amstislavskaya TG, Tikhonova MA (2018) Suppression of autophagy in the brain of transgenic mice with overexpression of A53T-mutant \u03b1-synuclein as an early event at synucleinopathy progression. Neurosci Lett 672:140\u2013144", "ArticleIdList": ["29203207"]}, {"Citation": "Tan EK, Skipper LM (2007) Pathogenic mutations in Parkinson disease. Hum Mutat 28:641\u2013653", "ArticleIdList": ["17385668"]}, {"Citation": "Fang Y-Q, Mao F, Zhu M-J, Li X-H (2019) Compound heterozygous mutations in PARK2 causing early-onset Parkinson disease: a case report. Medicine 98:e14228", "ArticleIdList": ["30702579", "6380659"]}, {"Citation": "Abou-Sleiman PM, Healy DG, Quinn N, Lees AJ, Wood NW (2003) The role of pathogenic DJ-1 mutations in Parkinson\u2019s disease. Ann Neurol 54:283\u2013286", "ArticleIdList": ["12953260"]}, {"Citation": "Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG (2004) Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science 304:1158\u20131160", "ArticleIdList": ["15087508"]}, {"Citation": "Huang E, Qu D, Huang T, Rizzi N, Boonying W, Krolak D, Ciana P, Woulfe J, Klein C, Slack RS (2017) PINK1-mediated phosphorylation of LETM1 regulates mitochondrial calcium transport and protects neurons against mitochondrial stress. Nat Commun 8:1\u201311"}, {"Citation": "Funayama M, Hasegawa K, Ohta E, Kawashima N, Komiyama M, Kowa H, Tsuji S, Obata F (2005) An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Annal Neurol 57:918\u2013921", "ArticleIdList": ["15880653"]}, {"Citation": "Volpicelli-Daley LA, Abdelmotilib H, Liu Z, Stoyka L, Daher JPL, Milnerwood AJ, Unni VK, Hirst WD, Yue Z, Zhao HT (2016) G2019S-LRRK2 expression augments \u03b1-synuclein sequestration into inclusions in neurons. J Neurosci 36:7415\u20137427", "ArticleIdList": ["27413152", "4945663"]}, {"Citation": "Nguyen APT, Daniel G, Vald\u00e9s P, Islam MS, Schneider BL, Moore DJ (2018) G2019S LRRK2 enhances the neuronal transmission of tau in the mouse brain. Hum Mol Genet 27:120\u2013134", "ArticleIdList": ["29088368"]}, {"Citation": "West AB (2017) Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease. Exp Neurol 298:236\u2013245", "ArticleIdList": ["28764903", "5693612"]}, {"Citation": "Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J (2012) A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature 488:96\u201399", "ArticleIdList": ["22801501"]}, {"Citation": "Goate A, Hardy J (2012) Twenty years of Alzheimer\u2019s disease-causing mutations. J Neurochem 120:3\u20138", "ArticleIdList": ["22122678"]}, {"Citation": "O\u2019brien RJ and Wong PC, (2011) Amyloid precursor protein processing and Alzheimer\u2019s disease. Annu Rev Neurosci 34:185\u2013204"}, {"Citation": "Kelleher RJ, Shen J (2017) Presenilin-1 mutations and Alzheimer\u2019s disease. Proc Natl Acad Sci 114:629\u2013631", "ArticleIdList": ["28082723"]}, {"Citation": "Endres K, Fahrenholz F (2010) Upregulation of the \u03b1-secretase ADAM10\u2013risk or reason for hope? FEBS J 277:1585\u20131596", "ArticleIdList": ["20136654"]}, {"Citation": "Yan R, Vassar R (2014) Targeting the \u03b2 secretase BACE1 for Alzheimer\u2019s disease therapy. Lancet Neurol 13:319\u2013329", "ArticleIdList": ["24556009", "4086426"]}, {"Citation": "Shamsi A, Anwar S, Mohammad T, Alajmi MF, Hussain A, Rehman M, Hasan GM, Islam A, Hassan M (2020) MARK4 inhibited by AChE inhibitors, donepezil and Rivastigmine tartrate: insights into Alzheimer\u2019s disease therapy. Biomolecules 10:789", "ArticleIdList": ["7277793"]}, {"Citation": "Anwar S, Shamsi A, Kar RK, Queen A, Islam A, Ahmad F, Hassan MI (2020) Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: towards therapeutic implications in neurodegenerative diseases. Int J Biol Macromol 161:596\u2013604", "ArticleIdList": ["32535203"]}, {"Citation": "Naz F, Shahbaaz M, Bisetty K, Islam A, Ahmad F, Hassan MI (2015) Designing new kinase inhibitor derivatives as therapeutics against common complex diseases: structural basis of microtubule affinity-regulating kinase 4 (MARK4) inhibition. Omics A J Integr Biol 19:700\u2013711"}, {"Citation": "Naqvi AAT, Jairajpuri DS, Noman OMA, Hussain A, Islam A, Ahmad F, Alajmi MF, Hassan MI (2020) Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: towards therapeutic management of Alzheimer\u2019s disease. J Biomol Struct Dyn 38:3892\u20133907", "ArticleIdList": ["31512980"]}, {"Citation": "Naz F, Anjum F, Islam A, Ahmad F, Hassan MI (2013) Microtubule affinity-regulating kinase 4: structure, function, and regulation. Cell Biochem Biophys 67:485\u2013499", "ArticleIdList": ["23471664"]}, {"Citation": "Annadurai N, Agrawal K, D\u017eub\u00e1k P, Hajd\u00fach M, Das V (2017) Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer\u2019s disease. Cell Mol Life Sci 74:4159\u20134169", "ArticleIdList": ["28634681"]}, {"Citation": "Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A (1998) Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702\u2013705", "ArticleIdList": ["9641683"]}, {"Citation": "Turab Naqvi AA, Hasan GM, Hassan M (2020) Targeting tau hyperphosphorylation via kinase inhibition: strategy to address Alzheimer\u2019s disease. Curr Top Med Chem 20:1059\u20131073", "ArticleIdList": ["31903881"]}, {"Citation": "Voura M, Khan P, Thysiadis S, Katsamakas S, Queen A, Hasan GM, Ali S, Sarli V, Hassan MI (2019) Probing the inhibition of microtubule affinity regulating kinase 4 by N-substituted acridones. Sci Rep 9:1\u201317"}, {"Citation": "Naz F, Sami N, Naqvi AT, Islam A, Ahmad F, Imtaiyaz Hassan M (2017) Evaluation of human microtubule affinity-regulating kinase 4 inhibitors: fluorescence binding studies, enzyme, and cell assays. J Biomol Struct Dyn 35:3194\u20133203", "ArticleIdList": ["27748164"]}, {"Citation": "Guha S, Fischer S, Johnson GV, Nehrke K (2020) Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model. Mol Neurodegener 15:1\u201316"}, {"Citation": "Riedel BC, Thompson PM, Brinton RD (2016) Age, APOE and sex: triad of risk of Alzheimer\u2019s disease. J Steroid Biochem Mol Biol 160:134\u2013147", "ArticleIdList": ["26969397", "4905558"]}, {"Citation": "Darweesh SK, Koudstaal PJ, Stricker BH, Hofman A, Ikram MA (2016) Trends in the incidence of Parkinson disease in the general population: the Rotterdam study. Am J Epidemiol 183:1018\u20131026", "ArticleIdList": ["27188952"]}, {"Citation": "Lee A, Gilbert RM (2016) Epidemiology of Parkinson disease. Neurol Clin 34:955\u2013965", "ArticleIdList": ["27720003"]}, {"Citation": "Longo VD, Antebi A, Bartke A, Barzilai N, Brown-Borg HM, Caruso C, Curiel TJ, De Cabo R, Franceschi C, Gems D (2015) Interventions to slow aging in humans: are we ready? Aging Cell 14:497\u2013510", "ArticleIdList": ["25902704", "4531065"]}, {"Citation": "Mielke MM, Vemuri P, Rocca WA (2014) Clinical epidemiology of Alzheimer\u2019s disease: assessing sex and gender differences. Clin Epidemiol 6:37", "ArticleIdList": ["24470773", "3891487"]}, {"Citation": "Liu W, Wong A, Law AC, Mok VC (2015) Cerebrovascular disease, amyloid plaques, and dementia. Stroke 46:1402\u20131407", "ArticleIdList": ["25765727"]}, {"Citation": "De Reuck J, Deramecourt V, Cordonnier C, Leys D, Maurage C, Pasquier F (2011) The impact of cerebral amyloid angiopathy on the occurrence of cerebrovascular lesions in demented patients with Alzheimer features: a neuropathological study. Eur J Neurol 18:913\u2013918", "ArticleIdList": ["21244582"]}, {"Citation": "Cordonnier C (2011) Brain microbleeds: more evidence, but still a clinical dilemma. Curr Opin Neurol 24:69\u201374", "ArticleIdList": ["21124218"]}, {"Citation": "G\u00fcnayd\u0131n ZY, \u00d6zer FF, Karag\u00f6z A, Bekta\u015f O, Karata\u015f MB, Vural A, Bayramo\u011flu A, \u00c7elik A, Yaman M (2016) Evaluation of cardiovascular risk in patients with Parkinson disease under levodopa treatment. JGC 13:75", "ArticleIdList": ["26918017"]}, {"Citation": "Li X, Song D, Leng SX (2015) Link between type 2 diabetes and Alzheimer\u2019s disease: from epidemiology to mechanism and treatment. Clin Interv Aging 10:549", "ArticleIdList": ["25792818", "4360697"]}, {"Citation": "G\u00f6tz J, Ittner L, Lim Y-A (2009) Common features between diabetes mellitus and Alzheimer\u2019s disease. Cell Mol Life Sci 66:1321\u20131325", "ArticleIdList": ["19266159"]}, {"Citation": "Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, Schatzkin A, Chen H (2011) Diabetes and risk of Parkinson\u2019s disease. Diabetes Care 34:910\u2013915", "ArticleIdList": ["21378214", "3064050"]}, {"Citation": "Chen J, Zhang C, Wu Y, Zhang D (2019) Association between hypertension and the risk of Parkinson\u2019s disease: a meta-analysis of analytical studies. Neuroepidemiology 52:181\u2013192", "ArticleIdList": ["30726850"]}, {"Citation": "Lennon MJ, Makkar SR, Crawford JD, Sachdev PS (2019) Midlife hypertension and Alzheimer\u2019s disease: a systematic review and meta-analysis. J Alzheimers Dis 71:307\u2013316", "ArticleIdList": ["31381518"]}, {"Citation": "Fonseca ACR, Resende R, Oliveira CR, Pereira CM (2010) Cholesterol and statins in Alzheimer\u2019s disease: current controversies. Exp Neurol 223:282\u2013293", "ArticleIdList": ["19782682"]}, {"Citation": "Simon KC, Chen H, Schwarzschild M, Ascherio A (2007) Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology 69:1688\u20131695", "ArticleIdList": ["17761552", "2391077"]}, {"Citation": "Pezzoli G, Cereda E (2013) Exposure to pesticides or solvents and risk of Parkinson disease. Neurology 80:2035\u20132041", "ArticleIdList": ["23713084"]}, {"Citation": "Klingelhoefer L, Reichmann H (2015) Pathogenesis of Parkinson disease\u2014the gut\u2013brain axis and environmental factors. Nat Rev Neurol 11:625\u2013636", "ArticleIdList": ["26503923"]}, {"Citation": "Reynolds E (2014) The neurology of folic acid deficiency. Handb Clin Neurol 120:927\u2013943", "ArticleIdList": ["24365361"]}, {"Citation": "Shen L, Ji H-F (2015) Associations between homocysteine, folic acid, vitamin B12 and Alzheimer\u2019s disease: insights from meta-analyses. J Alzheimers Dis 46:777\u2013790", "ArticleIdList": ["25854931"]}, {"Citation": "Trinh J, Farrer M (2013) Advances in the genetics of Parkinson disease. Nat Rev Neurol 9:445\u2013454", "ArticleIdList": ["23857047"]}, {"Citation": "Garc\u00eda-Alberca JM, Cruz B, Lara JP, Garrido V, Gris E, Lara A, Castilla C (2012) Disengagement coping partially mediates the relationship between caregiver burden and anxiety and depression in caregivers of people with Alzheimer\u2019s disease. Results from the M\u00c1LAGA-AD study. J Affect Disord 136:848\u2013856", "ArticleIdList": ["22030129"]}, {"Citation": "Zhou Z, Wang P, Fang Y (2018) Social engagement and its change are associated with dementia risk among Chinese older adults: a longitudinal study. Sci Rep 8:1\u20137"}, {"Citation": "Saczynski JS, Pfeifer LA, Masaki K, Korf ES, Laurin D, White L, Launer LJ (2006) The effect of social engagement on incident dementia: the Honolulu-Asia aging study. Am J Epidemiol 163:433\u2013440", "ArticleIdList": ["16410348"]}, {"Citation": "Topiwala H, Terrera GM, Stirland L, Saunderson K, Russ TC, Dozier MF, Ritchie CW (2018) Lifestyle and neurodegeneration in midlife as expressed on functional magnetic resonance imaging: a systematic review. Alzheimer\u2019s Dementia Transl Res Clin Interven 4:182\u2013194"}, {"Citation": "Postuma RB, Iranzo A, Hogl B, Arnulf I, Ferini-Strambi L, Manni R, Miyamoto T, Oertel W, Dauvilliers Y, Ju YE (2015) Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol 77:830\u2013839", "ArticleIdList": ["25767079", "5769479"]}, {"Citation": "Fernandez A, Santi A, Torres Aleman I (2018) Insulin peptides as mediators of the impact of life style in Alzheimer\u2019s disease. Brain Plasticity 4:3\u201315", "ArticleIdList": ["30564544", "6297900"]}, {"Citation": "Solfrizzi V, Panza F, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, Pilotto A (2011) Diet and Alzheimer\u2019s disease risk factors or prevention: the current evidence. Expert Rev Neurother 11:677\u2013708", "ArticleIdList": ["21539488"]}, {"Citation": "Hughes KC, Gao X, Kim IY, Wang M, Weisskopf MG, Schwarzschild MA, Ascherio A (2017) Intake of dairy foods and risk of Parkinson disease. Neurology 89:46\u201352", "ArticleIdList": ["28596209", "5496517"]}, {"Citation": "Costa J, Lunet N, Santos C, Santos J, Vaz-Carneiro A (2010) Caffeine exposure and the risk of Parkinson\u2019s disease: a systematic review and meta-analysis of observational studiess. J Alzheimers Dis 20:S221\u2013S238", "ArticleIdList": ["20182023"]}, {"Citation": "Terracciano A, An Y, Sutin AR, Thambisetty M, Resnick SM (2017) Personality change in the preclinical phase of Alzheimer disease. JAMA Psychiatry 74:1259\u20131265", "ArticleIdList": ["28975188", "5710607"]}, {"Citation": "Terracciano A, Sutin AR, An Y, O\u2019Brien RJ, Ferrucci L, Zonderman AB, Resnick SM (2014) Personality and risk of Alzheimer\u2019s disease: new data and meta-analysis. Alzheimers Dement 10:179\u2013186", "ArticleIdList": ["23706517"]}, {"Citation": "Sieurin J, Gustavsson P, Weibull CE, Feldman AL, Petzinger GM, Gatz M, Pedersen NL, Wirdefeldt K (2016) Personality traits and the risk for Parkinson disease: a prospective study. Eur J Epidemiol 31:169\u2013175", "ArticleIdList": ["26130127"]}, {"Citation": "Holmer J, Eriksdotter M, Schultzberg M, Pussinen PJ, Buhlin K (2018) Association between periodontitis and risk of Alzheimer\u2019s disease, mild cognitive impairment and subjective cognitive decline: a case\u2013control study. J Clin Periodontol 45:1287\u20131298", "ArticleIdList": ["30289998"]}, {"Citation": "Ngandu T, von Strauss E, Helkala E-L, Winblad B, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M (2007) Education and dementia: what lies behind the association? Neurology 69:1442\u20131450", "ArticleIdList": ["17909157"]}, {"Citation": "Bickel H, Kurz A (2009) Education, occupation, and dementia: the Bavarian school sisters study. Dement Geriatr Cogn Disord 27:548\u2013556", "ArticleIdList": ["19590201"]}, {"Citation": "Hsieh SH (2020) Depression in Parkinson\u2019s disease. In: UCLA"}, {"Citation": "Sami N, Kumar V, Islam A, Ali S, Ahmad F, Hassan I (2017) Exploring missense mutations in tyrosine kinases implicated with neurodegeneration. Mol Neurobiol 54:5085\u20135106", "ArticleIdList": ["27544236"]}, {"Citation": "Hrelia P, Sita G, Ziche M, Ristori E, Marino A, Cordaro M, Molteni R, Spero V, Malaguti M, Morroni F (2020) Common protective strategies in neurodegenerative disease: focusing on risk factors to target the cellular redox system. Oxid Med Cell Longev 2020:1\u201318"}, {"Citation": "Santos TCD, Gomes TM, Pinto BAS, Camara AL, Paes AMdA (2018) Naturally occurring acetylcholinesterase inhibitors and their potential use for Alzheimer\u2019s disease therapy. Front Pharmacol 9:1192", "ArticleIdList": ["30405413", "6201143"]}, {"Citation": "Tan C-C, Yu J-T, Wang H-F, Tan M-S, Meng X-F, Wang C, Jiang T, Zhu X-C, Tan L (2014) Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer\u2019s disease: a systematic review and meta-analysis. J Alzheimers Dis 41:615\u2013631", "ArticleIdList": ["24662102"]}, {"Citation": "Marucci G, Moruzzi M, Amenta F (2010) Donepezil in the treatment of Alzheimer\u2019s disease. Diagnosis and management in dementia. Elsevier, Amsterdam, pp 495\u2013510"}, {"Citation": "Svenningsson P, Westman E, Ballard C, Aarsland D (2012) Cognitive impairment in patients with Parkinson\u2019s disease: diagnosis, biomarkers, and treatment. Lancet Neurol 11:697\u2013707", "ArticleIdList": ["22814541"]}, {"Citation": "Dubois B, Tolosa E, Katzenschlager R, Emre M, Lees AJ, Schumann G, Pourcher E, Gray J, Thomas G, Swartz J (2012) Donepezil in Parkinson\u2019s disease dementia: a randomized, double-blind efficacy and safety study. Mov Disord 27:1230\u20131238", "ArticleIdList": ["22915447"]}, {"Citation": "Emre M, Ford PJ, Bilgi\u00e7 B, U\u00e7 EY (2014) Cognitive impairment and dementia in Parkinson\u2019s disease: practical issues and management. Mov Disord 29:663\u2013672", "ArticleIdList": ["24757114"]}, {"Citation": "Vanle B, Olcott W, Jimenez J, Bashmi L, Danovitch I, IsHak WW (2018) NMDA antagonists for treating the non-motor symptoms in Parkinson\u2019s disease. Transl Psychiatry 8:1\u201315"}, {"Citation": "Alam S, Lingenfelter KS, Bender AM, Lindsley CW (2017) Classics in chemical neuroscience: memantine. ACS Chem Neurosci 8:1823\u20131829", "ArticleIdList": ["28737885"]}, {"Citation": "Song X, Jensen M\u00d8, Jogini V, Stein RA, Lee C-H, Mchaourab HS, Shaw DE, Gouaux E (2018) Mechanism of NMDA receptor channel block by MK-801 and memantine. Nature 556:515\u2013519", "ArticleIdList": ["29670280", "5962351"]}, {"Citation": "Dong J, Cui Y, Li S, Le W (2016) Current pharmaceutical treatments and alternative therapies of Parkinson\u2019s disease. Curr Neuropharmacol 14:339\u2013355", "ArticleIdList": ["26585523", "4876590"]}, {"Citation": "Woods B, Aguirre E, Spector AE, Orrell M (2012) Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD005562.pub2", "ArticleIdList": ["10.1002/14651858.CD005562.pub2", "22336813"]}, {"Citation": "Spector A, Woods B, Orrell M (2008) Cognitive stimulation for the treatment of Alzheimer\u2019s disease. Expert Rev Neurother 8:751\u2013757", "ArticleIdList": ["18457532"]}, {"Citation": "Angelucci F, Peppe A, Carlesimo GA, Serafini F, Zabberoni S, Barban F, Shofany J, Caltagirone C, Costa A (2015) A pilot study on the effect of cognitive training on BDNF serum levels in individuals with Parkinson\u2019s disease. Front Hum Neurosci 9:130", "ArticleIdList": ["25852518", "4360779"]}, {"Citation": "Hackney ME, Bennett CG (2014) Dance therapy for individuals with Parkinson\u2019s disease: improving quality of life. Res Rev Parkinsonism 4:17\u201325"}, {"Citation": "Lihala S, Mitra S, Neogy S, Datta N, Choudhury S, Chatterjee K, Mondal B, Halder S, Roy A, Sengupta M (2020) Dance movement therapy in rehabilitation of Parkinson\u2019s disease\u2013a feasibility study. J Bodywork Mov Ther 26:12\u201317"}, {"Citation": "Fang R, Ye S, Huangfu J, Calimag DP (2017) Music therapy is a potential intervention for cognition of Alzheimer\u2019s disease: a mini-review. Transl Neurodegener 6:1\u20138"}, {"Citation": "Pereira APS, Marinho V, Gupta D, Magalh\u00e3es F, Ayres C, Teixeira S (2019) Music therapy and dance as gait rehabilitation in patients with Parkinson disease: a review of evidence. J Geriatr Psychiatry Neurol 32:49\u201356", "ArticleIdList": ["30558462"]}, {"Citation": "Lamotte G, Shah RC, Lazarov O, Corcos DM (2017) Exercise training for persons with Alzheimer\u2019s disease and caregivers: a review of dyadic exercise interventions. J Mot Behav 49:365\u2013377", "ArticleIdList": ["27870597"]}, {"Citation": "Duan Y, Lu L, Chen J, Wu C, Liang J, Zheng Y, Wu J, Rong P, Tang C (2018) Psychosocial interventions for Alzheimer\u2019s disease cognitive symptoms: a Bayesian network meta-analysis. BMC Geriatr 18:1\u201311"}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "12", "Day": "19"}, {"Year": "2021", "Month": "2", "Day": "23"}, {"Year": "2021", "Month": "3", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "9", "Hour": "12", "Minute": "13"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33687588", "10.1007/s11010-021-04120-6", "10.1007/s11010-021-04120-6"]}}], "PubmedBookArticle": []}